These substances were identified for action under the Chemicals Management Plan (CMP).
|CAS RN||DSL name||Draft screening assessment||Proposed conclusion on section 64 criteria||Follow-up activities|
|110-85-0||Piperazine||HTML||Does not meet||None planned at this time|
Although a risk to human health or the environment has not been identified at current levels of exposure, there may be a concern if exposure to this substance were to increase. As a result, program officials may consider this substance in future initiatives to track its commercial status and/or any new uses.
|March 2022||Anticipated publication of the final screening assessment.|
|March 13, 2021||Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 11.|
- Date modified: